SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 166,307 shares; 2025Q1: 566,212 shares; 2025Q2: 528,115 shares; 2025Q3: 726,204 shares; 2025Q4: 886,893 shares; 2026Q1: 1,035,496 shares; 2026Q2: 239,146 shares; 2026Q3: 688,954 shares 688,954 $33.3M 5.96% +449,808 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 239,861 shares; 2026Q2: 1,565,913 shares; 2026Q3: 2,260,594 shares 2,260,594 $33.1M 5.93% +694,681 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 87,748 shares; 2025Q3: 166,273 shares; 2025Q4: 391,783 shares; 2026Q1: 313,791 shares; 2026Q2: 283,657 shares; 2026Q3: 279,398 shares 279,398 $27.7M 4.95% -4,259 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 208,800 shares; 2025Q3: 245,378 shares; 2025Q4: not reported; 2026Q1: 200,919 shares; 2026Q2: 1,223,019 shares; 2026Q3: 989,345 shares 989,345 $24.7M 4.42% -233,674 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,712,778 shares; 2025Q1: 2,578,860 shares; 2025Q2: 601,781 shares; 2025Q3: 4,197,187 shares; 2025Q4: 966,698 shares; 2026Q1: 385,800 shares; 2026Q2: 348,408 shares; 2026Q3: 641,473 shares 641,473 $23.5M 4.2% +293,065 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 622,723 shares; 2026Q3: 649,924 shares 649,924 $23M 4.12% +27,201 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 96,716 shares; 2025Q1: 120,430 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 363,438 shares; 2026Q2: 346,914 shares; 2026Q3: 330,476 shares 330,476 $15.1M 2.71% -16,438 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 416,968 shares; 2025Q1: 192,352 shares; 2025Q2: 351,124 shares; 2025Q3: 241,637 shares; 2025Q4: not reported; 2026Q1: 80,492 shares; 2026Q2: 248,015 shares; 2026Q3: 333,332 shares 333,332 $13.5M 2.42% +85,317 Timeline ADPT ADAPTIVE BIOTECHNOLOGIES COR More: the full row for ADAPTIVE BIOTECHNOLOGIES COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,825 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 463,551 shares 463,551 $13.4M 2.4% new Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,382 shares; 2025Q4: 79,284 shares; 2026Q1: 85,502 shares; 2026Q2: 200,851 shares; 2026Q3: 150,776 shares 150,776 $13.3M 2.38% -50,075 Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 132,873 shares; 2026Q2: not reported; 2026Q3: 404,921 shares 404,921 $12M 2.16% new Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 136,139 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 32,377 shares; 2026Q1: 167,606 shares; 2026Q2: 106,926 shares; 2026Q3: 132,238 shares 132,238 $11.8M 2.11% +25,312 Timeline IMTX IMMATICS N.V More: the full row for IMMATICS N.V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 610,308 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,308,193 shares 1,308,193 $11.5M 2.06% new Timeline GRAL GRAIL INC More: the full row for GRAIL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 81,924 shares 81,924 $11.5M 2.06% new Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 134,178 shares; 2025Q1: not reported; 2025Q2: 32,255 shares; 2025Q3: not reported; 2025Q4: 21,067 shares; 2026Q1: 56,267 shares; 2026Q2: 37,243 shares; 2026Q3: 38,720 shares 38,720 $11.3M 2.02% +1,477 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,573 shares; 2025Q1: 240,826 shares; 2025Q2: 686,539 shares; 2025Q3: 713,463 shares; 2025Q4: 619,766 shares; 2026Q1: 525,639 shares; 2026Q2: 602,798 shares; 2026Q3: 418,527 shares 418,527 $11.1M 1.99% -184,271 Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 453,236 shares; 2026Q2: 523,648 shares; 2026Q3: 3,293,376 shares 3,293,376 $11M 1.96% +2,769,728 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,050,698 shares 2,050,698 $10.8M 1.93% new Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 506,067 shares 506,067 $10.8M 1.93% new Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 193,535 shares; 2025Q1: 318,782 shares; 2025Q2: not reported; 2025Q3: 185,380 shares; 2025Q4: 62,032 shares; 2026Q1: 281,632 shares; 2026Q2: 159,943 shares; 2026Q3: 50,000 shares 50,000 $10.3M 1.84% -109,943 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 83,576 shares; 2025Q1: 149,648 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,978 shares; 2026Q1: 129,577 shares; 2026Q2: 75,603 shares; 2026Q3: 145,760 shares 145,760 $9.61M 1.72% +70,157 Timeline ONC BEONE MEDICINES LTD More: the full row for BEONE MEDICINES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 25,051 shares 25,051 $9.17M 1.64% new Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 375,845 shares; 2025Q1: 274,633 shares; 2025Q2: not reported; 2025Q3: 192,295 shares; 2025Q4: 348,605 shares; 2026Q1: 140,755 shares; 2026Q2: 76,075 shares; 2026Q3: 222,287 shares 222,287 $8.27M 1.48% +146,212 Timeline JNJ JOHNSON & JOHNSON More: the full row for JOHNSON & JOHNSON Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 15,415 shares; 2026Q2: not reported; 2026Q3: 30,000 shares 30,000 $7.94M 1.42% new Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,710 shares; 2025Q4: 399,557 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 552,245 shares 552,245 $7.91M 1.42% new Timeline LLY ELI LILLY & CO More: the full row for ELI LILLY & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,759 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 6,599 shares 6,599 $7.64M 1.37% new Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 39,198 shares; 2026Q3: 109,926 shares 109,926 $7.19M 1.29% +70,728 Timeline CERS CERUS CORP More: the full row for CERUS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,967,942 shares 2,967,942 $7.06M 1.26% new Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,118,508 shares; 2025Q1: 853,472 shares; 2025Q2: 1,300,860 shares; 2025Q3: 1,589,580 shares; 2025Q4: 644,959 shares; 2026Q1: 746,494 shares; 2026Q2: 276,527 shares; 2026Q3: 201,334 shares 201,334 $6.8M 1.22% -75,193 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 154,034 shares; 2026Q2: not reported; 2026Q3: 471,718 shares 471,718 $6.63M 1.19% new Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 33,527 shares 33,527 $5.98M 1.07% new Timeline OABI OMNIAB INC More: the full row for OMNIAB INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,204,038 shares 1,204,038 $5.97M 1.07% new Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 184,173 shares 184,173 $5.9M 1.06% new Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 186,413 shares; 2025Q1: 250,564 shares; 2025Q2: 174,754 shares; 2025Q3: 1,017,311 shares; 2025Q4: not reported; 2026Q1: 1,594,491 shares; 2026Q2: 1,064,200 shares; 2026Q3: 396,865 shares 396,865 $5.3M 0.95% -667,335 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,101 shares; 2025Q1: not reported; 2025Q2: 631,586 shares; 2025Q3: 158,112 shares; 2025Q4: 290,049 shares; 2026Q1: 533,378 shares; 2026Q2: 602,686 shares; 2026Q3: 200,000 shares 200,000 $5.03M 0.9% -402,686 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 66,999 shares; 2025Q2: 165,885 shares; 2025Q3: 371,825 shares; 2025Q4: 161,659 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 123,760 shares 123,760 $4.75M 0.85% new Timeline CELC CELCUITY INC More: the full row for CELCUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 136,710 shares; 2025Q4: 118,333 shares; 2026Q1: 60,062 shares; 2026Q2: 98,203 shares; 2026Q3: 57,880 shares 57,880 $4.6M 0.82% -40,323 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,826 shares; 2025Q3: 545,275 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 195,143 shares 195,143 $4.58M 0.82% new Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 132,706 shares; 2025Q1: 180,255 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 360,876 shares; 2026Q1: 290,864 shares; 2026Q2: not reported; 2026Q3: 111,577 shares 111,577 $4.53M 0.81% new Timeline IFRX INFLARX NV More: the full row for INFLARX NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 725,019 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,228,255 shares; 2026Q3: 2,485,233 shares 2,485,233 $4.47M 0.8% -743,022 Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,146,182 shares; 2026Q3: 2,563,862 shares 2,563,862 $4.38M 0.79% +417,680 Timeline BDSX BIODESIX INC More: the full row for BIODESIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,004 shares; 2026Q2: 70,000 shares; 2026Q3: 141,548 shares 141,548 $4.22M 0.76% +71,548 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 61,403 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 42,200 shares 42,200 $4.15M 0.74% new Timeline SNY SANOFI SA More: the full row for SANOFI SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 99,880 shares 99,880 $4.12M 0.74% new Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 714,280 shares; 2026Q3: 647,406 shares 647,406 $4.07M 0.73% -66,874 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 289,823 shares; 2025Q2: not reported; 2025Q3: 63,019 shares; 2025Q4: not reported; 2026Q1: 205,622 shares; 2026Q2: 159,349 shares; 2026Q3: 54,791 shares 54,791 $3.88M 0.7% -104,558 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 104,585 shares; 2025Q2: 152,652 shares; 2025Q3: 150,573 shares; 2025Q4: 73,106 shares; 2026Q1: 180,658 shares; 2026Q2: 77,589 shares; 2026Q3: 159,044 shares 159,044 $3.87M 0.69% +81,455 Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 209,234 shares; 2026Q3: 51,804 shares 51,804 $3.87M 0.69% -157,430 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,320 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 187,320 shares 187,320 $3.86M 0.69% new Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,836 shares 200,836 $3.83M 0.69% new Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares; 2026Q2: 31,785 shares; 2026Q3: 91,757 shares 91,757 $3.47M 0.62% +59,972 Timeline EDSA EDESA BIOTECH INC More: the full row for EDESA BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 825,000 shares 825,000 $3.47M 0.62% new Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,000 shares; 2026Q3: 118,000 shares 118,000 $3.36M 0.6% 0 Timeline ISRG INTUITIVE SURGICAL INC More: the full row for INTUITIVE SURGICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,087 shares 8,087 $3.29M 0.59% new Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 315,226 shares; 2026Q2: not reported; 2026Q3: 137,973 shares 137,973 $3.27M 0.59% new Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,417,283 shares; 2026Q3: 1,287,804 shares 1,287,804 $3.21M 0.57% -1,129,479 Timeline CUE CUE BIOPHARMA INC More: the full row for CUE BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 66,995 shares; 2026Q3: 108,647 shares 108,647 $2.81M 0.5% +41,652 Timeline UTHR UNITED THERAPEUTICS CORP DEL More: the full row for UNITED THERAPEUTICS CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,264 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,646 shares 4,646 $2.52M 0.45% new Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 84,430 shares; 2025Q2: not reported; 2025Q3: 474,612 shares; 2025Q4: 835,200 shares; 2026Q1: 506,075 shares; 2026Q2: not reported; 2026Q3: 154,234 shares 154,234 $2.48M 0.44% new Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 138,200 shares 138,200 $2.37M 0.42% new Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 116,461 shares; 2026Q3: 27,260 shares 27,260 $2.27M 0.41% -89,201 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 106,610 shares; 2025Q1: 87,059 shares; 2025Q2: 61,578 shares; 2025Q3: 43,419 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 19,603 shares 19,603 $2.24M 0.4% new Timeline WGS GENEDX HOLDINGS CORP More: the full row for GENEDX HOLDINGS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,275 shares 29,275 $2.12M 0.38% new Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,389 shares; 2026Q1: 86,637 shares; 2026Q2: 80,907 shares; 2026Q3: 66,320 shares 66,320 $2.1M 0.38% -14,587 Timeline WHWK WHITEHAWK THERAPEUTICS INC More: the full row for WHITEHAWK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 424,082 shares; 2025Q4: 1,458,807 shares; 2026Q1: 939,369 shares; 2026Q2: 1,021,037 shares; 2026Q3: 495,980 shares 495,980 $1.86M 0.33% -525,057 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 30,125 shares; 2026Q3: 23,302 shares 23,302 $1.86M 0.33% -6,823 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 305,028 shares; 2026Q2: 171,671 shares; 2026Q3: 171,671 shares 171,671 $1.82M 0.33% 0 Timeline ARQT ARCUTIS BIOTHERAPEUTICS INC More: the full row for ARCUTIS BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,966 shares; 2025Q1: 440,073 shares; 2025Q2: 205,672 shares; 2025Q3: 411,893 shares; 2025Q4: 224,740 shares; 2026Q1: 413,792 shares; 2026Q2: 98,945 shares; 2026Q3: 61,189 shares 61,189 $1.62M 0.29% -37,756 Timeline AEMD AETHLON MED INC More: the full row for AETHLON MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 213,685 shares 213,685 $1.39M 0.25% new Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $1.25M 0.22% new Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,558 shares; 2026Q1: 375,000 shares; 2026Q2: 342,631 shares; 2026Q3: 352,689 shares 352,689 $1.12M 0.2% +10,058 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $1.1M 0.2% new Timeline QNRX QUOIN PHARMACEUTICALS LTD More: the full row for QUOIN PHARMACEUTICALS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 236,234 shares 236,234 $1.08M 0.19% new Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 52,000 shares 52,000 $1.04M 0.19% new Timeline STLN STARLING ONCOLOGY INC More: the full row for STARLING ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 156,663 shares 156,663 $990K 0.18% new Timeline CLRB CELLECTAR BIOSCIENCES INC More: the full row for CELLECTAR BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 354,938 shares; 2026Q3: 447,360 shares 447,360 $823K 0.15% +92,422 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,763 shares 21,763 $556K 0.1% new Timeline CALC CALCIMEDICA INC More: the full row for CALCIMEDICA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 248,972 shares 248,972 $403K 0.07% new Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000 $202K 0.04% new Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 597,409 shares; 2026Q2: 1,460,093 shares; 2026Q3: 44,129 shares 44,129 $166K 0.03% -1,415,964 Timeline VTGN VISTAGEN THERAPEUTICS INC More: the full row for VISTAGEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,328,492 shares; 2025Q1: 2,366,554 shares; 2025Q2: 2,413,254 shares; 2025Q3: 2,488,685 shares; 2025Q4: 616,749 shares; 2026Q1: 616,749 shares; 2026Q2: 616,749 shares; 2026Q3: 337,939 shares 337,939 $24.7K <0.01% -278,810 Timeline